Abstract A24: A possible role for GSK3β in epithelial ovarian cancer chemoresistance by epigenetic regulation

Noelle L. Cutter; Mena Yacoub; Robert D. Lucito; Nevenka Dimitrova; Elena Lum; Michael Vigliotti; Kazimierz Wrzeszczynski; Douglas A. Levine

doi:10.1158/1078-0432.OVCA13-A24

Abstract A24: A possible role for GSK3β in epithelial ovarian cancer chemoresistance by epigenetic regulation

Noelle L. Cutter
, Mena Yacoub
, Robert D. Lucito
, Nevenka Dimitrova
, Elena Lum
, Michael Vigliotti
, Kazimierz Wrzeszczynski
, Douglas A. Levine

Biology, Chemistry, Environmental Studies

Hofstra University
Philips
Cold Spring Harbor Laboratory
New York University

Producción científica: Abstract › revisión exhaustiva

Idioma original	American English
DOI	https://doi.org/10.1158/1078-0432.OVCA13-A24
Estado	Published - oct 1 2013

Disciplines

Genetics
Biology
Oncology
Immunology and Infectious Disease

Acceder al documento

10.1158/1078-0432.OVCA13-A24Licencia: Unspecified

Citar esto

@conference{5c63b9d9f5634d6faf409b5c2eee5296,

title = "Abstract A24: A possible role for GSK3β in epithelial ovarian cancer chemoresistance by epigenetic regulation",

author = "Cutter, \{Noelle L.\} and Mena Yacoub and Lucito, \{Robert D.\} and Nevenka Dimitrova and Elena Lum and Michael Vigliotti and Kazimierz Wrzeszczynski and Levine, \{Douglas A.\}",

note = "Ovarian cancers are highly heterogeneous and while chemotherapy is the preferred treatment many patients are intrinsically resistant or quickly develop resistance. Furthermore, all tumors that recur ultimately become resistant. Recent evidence suggests that epigenetic deregulation may be a key factor in the onset and maintenance of chemoresistance.",

year = "2013",

month = oct,

day = "1",

doi = "10.1158/1078-0432.OVCA13-A24",

language = "American English",

}

TY - CONF

T1 - Abstract A24: A possible role for GSK3β in epithelial ovarian cancer chemoresistance by epigenetic regulation

AU - Cutter, Noelle L.

AU - Yacoub, Mena

AU - Lucito, Robert D.

AU - Dimitrova, Nevenka

AU - Lum, Elena

AU - Vigliotti, Michael

AU - Wrzeszczynski, Kazimierz

AU - Levine, Douglas A.

N1 - Ovarian cancers are highly heterogeneous and while chemotherapy is the preferred treatment many patients are intrinsically resistant or quickly develop resistance. Furthermore, all tumors that recur ultimately become resistant. Recent evidence suggests that epigenetic deregulation may be a key factor in the onset and maintenance of chemoresistance.

PY - 2013/10/1

Y1 - 2013/10/1

U2 - 10.1158/1078-0432.OVCA13-A24

DO - 10.1158/1078-0432.OVCA13-A24

M3 - Abstract

ER -